Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTD1801 in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
NCT06353347Phase 3Completed
- Sponsor
- HighTide Therapeutics, Inc.
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of berberine ursodeoxycholate in type 2 diabetes mellitus (T2DM), sponsored by HighTide Therapeutics, Inc.. Started Nov 2023; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06353347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06353347.